Shenzhen Kangtai Biological Products Co Ltd Net Asset Quality Index
Shenzhen Kangtai Biological Products Co Ltd net asset quality index. Shenzhen Kangtai Biological Products Co Ltd (300601) has a Net Asset Quality Index of 69.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥13.93 Billion minus total liabilities of CN¥4.27 Billion yields net assets of CN¥9.66 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Shenzhen Kangtai Biological Products Co book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Shenzhen Kangtai Biological Products Co Ltd (2012–2025)
Net asset quality index of Shenzhen Kangtai Biological Products Co Ltd from 2012 to 2025. This chart shows how Shenzhen Kangtai Biological Products Co Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the index stands at 69.4%, representing net assets of CN¥9.66 Billion against total assets of CN¥13.93 Billion CNY. Check Shenzhen Kangtai Biological Products Co (300601) strategic investment index to assess the company's strategic physical and investment asset allocation.
Shenzhen Kangtai Biological Products Co Ltd Net Asset Quality Index by Year (2012–2025)
Shenzhen Kangtai Biological Products Co Ltd net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Shenzhen Kangtai Biological Products Co Ltd from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shenzhen Kangtai Biological Products Co (300601) total market value.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 68.3% | CN¥9.63 Billion | CN¥14.10 Billion | CN¥4.46 Billion | ▲ +2.0 pp |
| 2024 | 66.3% | CN¥9.66 Billion | CN¥14.56 Billion | CN¥4.90 Billion | ▲ +3.1 pp |
| 2023 | 63.3% | CN¥9.54 Billion | CN¥15.09 Billion | CN¥5.54 Billion | ▼ -1.9 pp |
| 2022 | 65.2% | CN¥8.99 Billion | CN¥13.79 Billion | CN¥4.80 Billion | ▲ +0.4 pp |
| 2021 | 64.8% | CN¥9.17 Billion | CN¥14.15 Billion | CN¥4.98 Billion | ▼ -13.1 pp |
| 2020 | 77.9% | CN¥7.46 Billion | CN¥9.58 Billion | CN¥2.12 Billion | ▲ +8.2 pp |
| 2019 | 69.7% | CN¥2.75 Billion | CN¥3.95 Billion | CN¥1.20 Billion | ▲ +14.7 pp |
| 2018 | 55.0% | CN¥1.84 Billion | CN¥3.34 Billion | CN¥1.50 Billion | ▲ +6.5 pp |
| 2017 | 48.4% | CN¥1.07 Billion | CN¥2.21 Billion | CN¥1.14 Billion | ▲ +2.5 pp |
| 2016 | 45.9% | CN¥735.00 Million | CN¥1.60 Billion | CN¥865.90 Million | ▼ -2.6 pp |
| 2015 | 48.5% | CN¥647.12 Million | CN¥1.33 Billion | CN¥686.71 Million | ▲ +5.0 pp |
| 2014 | 43.5% | CN¥583.81 Million | CN¥1.34 Billion | CN¥758.25 Million | ▲ +9.9 pp |
| 2013 | 33.6% | CN¥372.17 Million | CN¥1.11 Billion | CN¥734.74 Million | ▼ -4.3 pp |
| 2012 | 37.9% | CN¥431.21 Million | CN¥1.14 Billion | CN¥705.50 Million | — |